Listen Live

FDA approves new drug to protect infants, toddlers from RSV

WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.

RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.

The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.

The full article is available at ozarksfirst.com.

More from Local News

Listen Live to Our Family of Stations

     

Ways To Listen